These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3078904)

  • 1. Survival in patients with heart failure: focus on captopril.
    DiBianco R
    Clin Ther; 1988; 10(2):204-15. PubMed ID: 3078904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Ghose JC; Chakraborty S; Mondal M; Bhandari B
    J Assoc Physicians India; 1993 May; 41(5):269-71. PubMed ID: 8300456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in congestive heart failure: have we made a difference?
    Firth BG; Yancy CW
    Am J Med; 1990 Jan; 88(1N):3N-8N. PubMed ID: 2195883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year clinical and echocardiographic follow-up of patients with congestive cardiomyopathy treated with captopril compared to placebo.
    Keren G; Pardes A; Eschar Y; Koifman B; Scherez J; Geleranter I; Laniado S
    Isr J Med Sci; 1994 Jan; 30(1):90-8. PubMed ID: 8138400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure.
    Paul SD; Kuntz KM; Eagle KA; Weinstein MC
    Arch Intern Med; 1994 May; 154(10):1143-9. PubMed ID: 8185426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Observations on the natural history of heart failure. Changes due to the therapeutic use of captopril].
    Ziletti G; Spotti A; Carini M; Distante R; Astorri E
    Minerva Cardioangiol; 1992 Mar; 40(3):71-8. PubMed ID: 1630678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
    Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
    Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from V-HeFT: questions for V-HeFT II and the future therapy of heart failure.
    Cohn JN
    Herz; 1991 Sep; 16 Spec No 1():267-71. PubMed ID: 1820292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Captopril treatment--2-year period of observation].
    Tkaczewski W; Adamska-Dyniewska H; Bała T; Gajewska B; Chojnowska-Jezierska J; Rosiek S; Słomka S
    Pol Tyg Lek; 1993 Apr 5-12; 48(14-15):318-20. PubMed ID: 8415245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vasodilator therapy in congestive heart failure. Effects on mortality.
    Greenberg B
    Cardiol Clin; 1994 Feb; 12(1):87-99. PubMed ID: 8181028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vasodilator agents in chronic heart failure: which is the best option?].
    Corbalán R; Kunstmann S; Jalil J
    Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure.
    Pfeffer JM; Pfeffer MA; Braunwald E
    Circulation; 1987 Jan; 75(1 Pt 2):I149-55. PubMed ID: 3539404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial.
    Fonarow GC; Chelimsky-Fallick C; Stevenson LW; Luu M; Hamilton MA; Moriguchi JD; Tillisch JH; Walden JA; Albanese E
    J Am Coll Cardiol; 1992 Mar; 19(4):842-50. PubMed ID: 1545080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of captopril in left ventricular failure during the acute stage of myocardial infarction].
    Kayanakis JG; Breton J; Maillet J; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1983 Dec; 76(12):1369-74. PubMed ID: 6422872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril-furosemide survival study in experimental heart failure.
    Mougenot N; Bos R; Médiani O; Lechat P
    Fundam Clin Pharmacol; 2005 Aug; 19(4):457-64. PubMed ID: 16011733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of ACE inhibitors in heart failure. Lessons of CONSENSUS, SOLVD and V-HeFTII].
    Dessì-Fulgheri P; Paci MV; Rappelli A
    Ann Ital Med Int; 1994 Oct; 9 Suppl():16S-18S. PubMed ID: 7857751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II).
    Konstam MA; Neaton JD; Poole-Wilson PA; Pitt B; Segal R; Sharma D; Dasbach EJ; Carides GW; Dickstein K; Riegger G; Camm AJ; Martinez FA; Bradstreet DC; Ikeda LS; Santoro EP;
    Am Heart J; 2005 Jul; 150(1):123-31. PubMed ID: 16084158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.